HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/3/F474    most recent 00452.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Wamsley-Davis, A. Articles by Sheikh-Hamad, D. Search for Related Content PubMed PubMed Citation Articles by Wamsley-Davis, A. Articles by Sheikh-Hamad, D.

AT_1A-mediated activation of kidney JNK1 and SMAD2 in obstructive uropathy: preservation of kidney tissue mass using candesartan

¹Renal Section, Department of Medicine, and ²Renal Pathology Laboratory, Department of Pathology, Baylor College of Medicine, Houston, Texas 77030

Submitted 29 December 2003 ; accepted in final form 21 April 2004

Literature suggests the involvement of the renin-angiotensin system and transforming growth factor (TGF)- in the renal injury that follows chronic ureteric obstruction. SMAD proteins and the JNK1 cascade are essential components of TGF- signaling machinery, and recent data suggest cooperative interaction between JNK1 and SMAD proteins in TGF--mediated gene expression. We used a rat model of chronic unilateral ureteric obstruction to study the effects of candesartan, an AT_1A-receptor blocker, on tissue morphology and the activities of JNK1 and SMAD2 protein in the kidney. Ureteric obstruction for 28 days leads to interstitial fibrosis, tubule atrophy, and marked activation of SMAD2 and JNK1, without significant change in p38 kinase or ERK. Candesartan treatment, however, attenuated the chronic tubulointerstitial injury in obstructed kidneys and was associated with significant preservation of kidney tissue mass. Furthermore, treatment with candesartan diminished JNK1 activity and downregulated SMAD2 protein and activity in obstructed kidneys. In conclusion, obstructed kidneys showed chronic tubulointerstitial injury, which was associated with JNK1 and SMAD2 activation. The renoprotective effects afforded by AT_1A-receptor blockade in obstructive uropathy are consistent with attenuation of JNK1- and SMAD2-mediated renal injury.

MAPK; transforming growth factor-; monocyte chemotactic protein-1; AT₂; angiotensin II

This article has been cited by other articles:

				A. Eskild-Jensen, L. F. Paulsen, L. Wogensen, P. Olesen, L. Pedersen, J. Frokiaer, and J. R. Nyengaard AT1 receptor blockade prevents interstitial and glomerular apoptosis but not fibrosis in pigs with neonatal induced partial unilateral ureteral obstruction Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1771 - F1781. [Abstract] [Full Text] [PDF]

				M. Ruiz-Ortega, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido TGF-{beta} signaling in vascular fibrosis Cardiovasc Res, May 1, 2007; 74(2): 196 - 206. [Abstract] [Full Text] [PDF]

				S. O. Topcu, M. Pedersen, R. Norregaard, G. Wang, M. Knepper, J. C. Djurhuus, S. Nielsen, T. M. Jorgensen, and J. Frokiaer Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction Am J Physiol Renal Physiol, February 1, 2007; 292(2): F736 - F748. [Abstract] [Full Text] [PDF]

				A. M. Jensen, C. Li, H. A. Praetorius, R. Norregaard, S. Frische, M. A. Knepper, S. Nielsen, and J. Frokiaer Angiotensin II mediates downregulation of aquaporin water channels and key renal sodium transporters in response to urinary tract obstruction Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1021 - F1032. [Abstract] [Full Text] [PDF]